Month: January 2024

TORONTO, Jan. 10, 2024 (GLOBE NEWSWIRE) — Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today that it has received a No Objection Letter from Health Canada to conduct a Phase II trial for LSALT peptide, targeting the prevention and treatment of cardiac surgery-associated acute kidney injury (CS-AKI). LSALT peptide is the Company’s lead drug candidate for preventing and treating inflammation injury in the kidneys, lungs and liver. The Phase II trial is an international multi-center, randomized, double-blind, placebo-controlled study of LSALT peptide. The primary objective of the trial is to evaluate the percentage of subjects with AKI within 7 days following on-pump (heart-lung machine) cardiac surgery, defined by the KDIGO (Kidney Disease: Improving Global Outcomes) criteria. There...

The new Rapid Sterility application includes a novel, proprietary test kit that has been developed for use with the Company’s fully automated Growth Direct system and delivers time to organism detection in as little as 12 hours and final time-to-result in as little as one to three days Commercial launch of the Growth Direct Rapid Sterility application is expected by mid-year 2024 LOWELL, Mass., Jan. 10, 2024 (GLOBE NEWSWIRE) — Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced that it expects the commercial launch of the Growth Direct Rapid Sterility application by mid-year 2024. Sterility testing is the final quality check...

Full year 2023 total revenue expected to be between $22.4 million and $22.6 million, representing growth of over 30% compared to the prior year Fourth quarter 2023 total revenue expected to be between $6.2 million and $6.4 million, representing growth of approximately 45% compared to the prior-year period   Finished 2023 with approximately $95 million in cash and investments Company to present at the 42nd annual J.P. Morgan Healthcare Conference on January 11, 2024 LOWELL, Mass., Jan. 10, 2024 (GLOBE NEWSWIRE) — Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced preliminary unaudited fourth quarter and full year 2023 revenue. Select...

Tel Aviv, Israel / Vancouver, Canada, Jan. 10, 2024 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq, CSE: CMND), (FSE: CWY) (“Clearmind” or the “company”), a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, today announced it has completed a Type A meeting with the U.S. Food and Drug Administration (FDA) to discuss  the Company’s clinical trial of its proprietary MEAI-based, CMND-100 compound, for the treatment of Alcohol Use Disorder treatment (AUD) using its novel psychedelic- based therapy.  “We’re pleased to report we recently met with the FDA to align on the content of our IND resubmission for CMND-100,” said Dr. Adi Zuloff-Shani, CEO of Clearmind Medicine. “The meeting was informative and productive,...

Aspocomp Group Plc, Inside Information, January 10, 2024, at 2:10 p.m. (Finnish time) Aspocomp is lowering its net sales and operating result forecast for 2023 due to low net sales, weakened product mix and significantly higher material costs. Material consumption was increased by a temporary production process disruption during the fourth quarter. Material usage is estimated to normalize during the first quarter. The production disruption also affected production volumes and net sales at the end of the year. According to preliminary, unaudited figures, the 2023 net sales are expected to amount to approximately EUR 32.3 million and the 2023 operating result to approximately EUR 1.7–1.9 million negative.   In its previous outlook for 2023 (released on October 27, 2023), Aspocomp estimated that its net sales for 2023 would be clearly below...

SURREY, British Columbia, Jan. 10, 2024 (GLOBE NEWSWIRE) — RecycLiCo Battery Materials Inc. (“RecycLiCo” or the “Company”), TSX.V: AMY, OTCQB: AMYZF, FSE: ID4, a pioneer in sustainable lithium-ion battery recycling technology, is pleased to announce that the Company’s recycled lithium carbonate, from lithium-ion battery waste, has passed a comprehensive suite of tests conducted by a battery materials company in Asia. RecycLiCo’s lithium carbonate, contained in a Lithium Iron Phosphate (LFP) battery, was subjected to several industry-standard tests, including LFP fabrication and cell testing. The results indicate that the Company’s lithium carbonate has met, and surpassed the specifications required by the battery materials company, thus demonstrating the recycled product’s battery-grade quality. This success arrives...

VIRGINIA CITY, Nev., Jan. 10, 2024 (GLOBE NEWSWIRE) — Comstock Inc. (NYSE: LODE) (“Comstock” and the “Company”) announced today that it has been notified by the Nevada Division of Environmental Protection of the issuance of the new Class II Air Quality Operating Permit for its Solar Panel Recycling Facility. The world remains focused on the production of energy generation and storage technologies to reduce reliance on fossil fuels, and especially photovoltaics. The substantial majority of U.S. solar panels have been deployed in the southwest region of U.S., primarily California, Nevada, and Arizona with a remarkable acceleration of the decommissioning of these end-of-life solar panels occurring now. Comstock is currently building a facility that includes technologies for efficiently crushing, conditioning, extracting, and recycling...

Beam Global Wins for EV ARC™ Sustainable EV Charging SystemBeam Global Receives Top Product of the Year Award from Environment + Energy LeaderBeam Global Receives Top Product of the Year Award from Environment + Energy Leader; Beam Global Wins for EV ARC™ Sustainable EV Charging SystemSAN DIEGO, Jan. 10, 2024 (GLOBE NEWSWIRE) — Beam Global, (Nasdaq: BEEM, BEEMW), a leading provider of innovative and sustainable infrastructure solutions for the electrification of transportation and energy security, announced that the EV ARC™ system has been honored with the prestigious Top Product of the Year Award 2023 by the Environment + Energy (E+E) Leader Awards program. This accolade recognizes the EV ARC™ sustainable EV charging system as an exemplary product making great strides in energy advancement. Off-grid...

Mineralization at Las Primas shows strong similarities to Guadalupe EastFigure 1 Drill Program Progress_Jan 2024Figure 1 Drill Program Progress_Jan 2024Figure 2 Guadalupe East & Las Primas Drill Program Progress_Jan 2024Figure 2 Guadalupe East & Las Primas Drill Program Progress_Jan 2024Figure 3 Guadalupe East & Las Primas Grade ShellsFigure 3 Guadalupe East & Las Primas Grade ShellsFigure 4 Section GE-4950E_Jan 2024Figure 4 Section GE-4950E_Jan 2024May 2023 Mineral Resource EstimateMay 2023 Mineral Resource EstimateVANCOUVER, British Columbia, Jan. 10, 2024 (GLOBE NEWSWIRE) — Prime Mining Corp. (“Prime” or the “Company”) (TSX: PRYM) (OTCQX: PRMNF) (Frankfurt: 04V3) is reporting expansion and generative drill results from its 2023 drill program at the Company’s Los...